TABITHA HARRIS: Open Payments
NPI 1841528643 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 29 payments from 9 companies in 2025. Trend: 2023 $103 · 2024 $412 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $317 |
| Abbott Laboratories | 3 | $79 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| BETA BIONICS, INC. | 3 | $54 |
| Insulet Corporation | 2 | $48 |
| Amgen Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: Ozempic, FREESTYLE LIBRE 3, GVOKE HYPOPEN, iLet Bionic Pancreas, Omnipod, EVENITY, RECORLEV, MINIMED 780G.
Industry payments across MA — which companies pay providers there.
